Literature DB >> 8986781

Effect of genetic background on the contribution of New Zealand black loci to autoimmune lupus nephritis.

S J Rozzo1, T J Vyse, C G Drake, B L Kotzin.   

Abstract

Autoimmune diseases such as systemic lupus erythematosus are complex genetic traits with contributions from major histocompatibility complex (MHC) genes and multiple unknown non-MHC genes. Studies of animal models of lupus have provided important insight into the immunopathogenesis of disease, and genetic analyses of these models overcome certain obstacles encountered when studying human patients. Genome-wide scans of different genetic crosses have been used to map several disease-linked loci in New Zealand hybrid mice. Although some consensus exists among studies mapping the New Zealand Black (NZB) and New Zealand White (NZW) loci that contribute to lupus-like disease, considerable variability is also apparent. A variable in these studies is the genetic background of the non-autoimmune strain, which could influence genetic contributions from the affected strain. A direct examination of this question was undertaken in the present study by mapping NZB nephritis-linked loci in backcrosses involving different non-autoimmune backgrounds. In a backcross with MHC-congenic C57BL/6J mice, H2z appeared to be the strongest genetic determinant of severe lupus nephritis, whereas in a backcross with congenic BALB/cJ mice, H2z showed no influence on disease expression. NZB loci on chromosomes 1, 4, 11, and 14 appeared to segregate with disease in the BALB/cJ cross, but only the influence of the chromosome 1 locus spanned both crosses and showed linkage with disease when all mice were considered. Thus, the results indicate that contributions from disease-susceptibility loci, including MHC, may vary markedly depending on the non-autoimmune strain used in a backcross analysis. These studies provide insight into variables that affect genetic heterogeneity and add an important dimension of complexity for linkage analyses of human autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8986781      PMCID: PMC26374          DOI: 10.1073/pnas.93.26.15164

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Effects of major histocompatibility complex on autoimmune disease of H-2-congenic New Zealand mice.

Authors:  S Hirose; K Kinoshita; S Nozawa; H Nishimura; T Shirai
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

Review 2.  Genetic contributions to lupus-like disease in (NZB x NZW)F1 mice.

Authors:  C G Drake; S J Rozzo; T J Vyse; E Palmer; B L Kotzin
Journal:  Immunol Rev       Date:  1995-04       Impact factor: 12.988

Review 3.  The basis of autoimmunity: Part II. Genetic predisposition.

Authors:  A N Theofilopoulos
Journal:  Immunol Today       Date:  1995-03

4.  A comprehensive genetic map of the mouse genome.

Authors:  W F Dietrich; J Miller; R Steen; M A Merchant; D Damron-Boles; Z Husain; R Dredge; M J Daly; K A Ingalls; T J O'Connor
Journal:  Nature       Date:  1996-03-14       Impact factor: 49.962

5.  Polygenic control of susceptibility to murine systemic lupus erythematosus.

Authors:  L Morel; U H Rudofsky; J A Longmate; J Schiffenbauer; E K Wakeland
Journal:  Immunity       Date:  1994-06       Impact factor: 31.745

6.  Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain.

Authors:  L Morel; Y Yu; K R Blenman; R A Caldwell; E K Wakeland
Journal:  Mamm Genome       Date:  1996-05       Impact factor: 2.957

7.  The BM12 mutation and autoantibodies to dsDNA in NZB.H-2bm12 mice.

Authors:  B L Chiang; E Bearer; A Ansari; K Dorshkind; M E Gershwin
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

8.  Mapping of a gene for hypergammaglobulinemia to the distal region on chromosome 4 in NZB mice and its contribution to systemic lupus erythematosus in (NZB x NZW)F1 mice.

Authors:  S Hirose; H Tsurui; H Nishimura; Y Jiang; T Shirai
Journal:  Int Immunol       Date:  1994-12       Impact factor: 4.823

9.  Statistical evaluation of multiple-locus linkage data in experimental species and its relevance to human studies: application to nonobese diabetic (NOD) mouse and human insulin-dependent diabetes mellitus (IDDM).

Authors:  N Risch; S Ghosh; J A Todd
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

10.  Requirement of H-2 heterozygosity for autoimmunity in (NZB X NZW)F1 hybrid mice.

Authors:  S Hirose; G Ueda; K Noguchi; T Okada; I Sekigawa; H Sato; T Shirai
Journal:  Eur J Immunol       Date:  1986-12       Impact factor: 5.532

View more
  21 in total

1.  Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice.

Authors:  Marton Keszei; Yvette E Latchman; Vijay K Vanguri; Daniel R Brown; Cynthia Detre; Massimo Morra; Carolina V Arancibia-Carcamo; Carolina V Arancibia; Elahna Paul; Silvia Calpe; Wilson Castro; Ninghai Wang; Cox Terhorst; Arlene H Sharpe
Journal:  Int Immunol       Date:  2011-01-28       Impact factor: 4.823

2.  Hyper IgE in New Zealand black mice due to a dominant-negative CD23 mutation.

Authors:  Graham Lewis; Eleni Rapsomaniki; Tiphaine Bouriez; Tanya Crockford; Helen Ferry; Robert Rigby; Timothy Vyse; Teresa Lambe; Richard Cornall
Journal:  Immunogenetics       Date:  2004-10-19       Impact factor: 2.846

3.  Genes mediating environment interactions in type 1 diabetes.

Authors:  Erik Biros; Margaret A Jordan; Alan G Baxter
Journal:  Rev Diabet Stud       Date:  2006-02-10

Review 4.  Susceptibility loci for lupus: a guiding light from murine models?

Authors:  B L Kotzin
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 5.  Genetic studies in systemic autoimmunity and aging.

Authors:  D H Kono; A N Theofilopoulos
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 6.  TLR7 and TLR9 in SLE: when sensing self goes wrong.

Authors:  T Celhar; R Magalhães; A-M Fairhurst
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

7.  Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus.

Authors:  T J Vyse; R K Halterman; S J Rozzo; S Izui; B L Kotzin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

8.  An Lck-cre transgene accelerates autoantibody production and lupus development in (NZB × NZW)F1 mice.

Authors:  R K Nelson; K A Gould
Journal:  Lupus       Date:  2015-09-18       Impact factor: 2.911

9.  Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model.

Authors:  Khie Khiong; Masaaki Murakami; Chika Kitabayashi; Naoko Ueda; Shin-ichiro Sawa; Akemi Sakamoto; Brian L Kotzin; Stephen J Rozzo; Katsuhiko Ishihara; Marileila Verella-Garcia; John Kappler; Philippa Marrack; Toshio Hirano
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

10.  Development of murine lupus involves the combined genetic contribution of the SLAM and FcgammaR intervals within the Nba2 autoimmune susceptibility locus.

Authors:  Trine N Jørgensen; Jennifer Alfaro; Hilda L Enriquez; Chao Jiang; William M Loo; Stephanie Atencio; Melanie R Gubbels Bupp; Christina M Mailloux; Troy Metzger; Shannon Flannery; Stephen J Rozzo; Brian L Kotzin; Mario Rosemblatt; María Rosa Bono; Loren D Erickson
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.